HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carine Ali Selected Research

tPA stop

10/20042,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carine Ali Research Topics

Disease

19Stroke (Strokes)
12/2018 - 12/2002
10Ischemic Stroke
12/2018 - 03/2007
5Ischemia
12/2010 - 01/2003
4Brain Injuries (Brain Injury)
02/2013 - 02/2003
4Necrosis
02/2013 - 12/2002
3Thrombosis (Thrombus)
01/2022 - 02/2012
3Thrombotic Stroke
08/2017 - 10/2011
2Alzheimer Disease (Alzheimer's Disease)
01/2022 - 10/2012
2Hemorrhage
01/2022 - 02/2015
2Brain Ischemia (Cerebral Ischemia)
01/2021 - 01/2003
2Cerebral Hemorrhage
04/2013 - 10/2012
2Brain Diseases (Brain Disorder)
06/2011 - 02/2006
1Hydrocephalus (Hydrocephaly)
01/2022
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2022
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
08/2017
1Intracranial Hemorrhages (Intracranial Hemorrhage)
08/2017
1Carotid Artery Thrombosis
08/2017
1Neuroinflammatory Diseases
01/2016
1Brain Edema (Cerebral Edema)
04/2013
1Hematoma
04/2013
1Hemorrhagic Stroke
04/2013
1Traumatic Brain Injuries (Traumatic Brain Injury)
10/2012
1Inflammation (Inflammations)
10/2012
1Myocardial Infarction
02/2012
1Hypersensitivity (Allergy)
01/2011
1Schizophrenia (Dementia Praecox)
08/2007
1Multiple Sclerosis
04/2007
1Central Nervous System Diseases (CNS Diseases)
02/2006
1Wounds and Injuries (Trauma)
12/2004

Drug/Important Bio-Agent (IBA)

24Tissue Plasminogen Activator (Alteplase)FDA Link
01/2022 - 12/2002
8N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
04/2013 - 12/2005
5Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2017 - 08/2004
4Plasminogen Activators (Plasminogen Activator)IBA
12/2018 - 12/2002
4N-Methylaspartate (NMDA)IBA
04/2013 - 12/2002
4CytokinesIBA
06/2011 - 01/2003
4Serine Proteases (Serine Protease)IBA
09/2006 - 12/2002
4Transforming Growth Factor beta (TGF-beta)IBA
02/2006 - 12/2002
3PlasminogenIBA
12/2018 - 02/2012
3FibrinolysinFDA Link
12/2018 - 06/2011
2ThrombinFDA Link
08/2017 - 12/2010
2Pharmaceutical PreparationsIBA
08/2011 - 06/2011
2AntibodiesIBA
08/2011 - 12/2010
2CannabinoidsIBA
01/2011 - 04/2007
2Neuroprotective AgentsIBA
04/2007 - 01/2003
2Transforming Growth Factor beta1 (TGF beta 1)IBA
10/2003 - 01/2003
1Bumetanide (Bumex)FDA LinkGeneric
01/2022
1Amyloid (Amyloid Fibrils)IBA
01/2022
1N 30IBA
01/2021
1ferric chlorideIBA
08/2017
1Collagenases (Collagenase)FDA Link
08/2017
1von Willebrand FactorIBA
08/2017
1Glutamate Receptors (Glutamate Receptor)IBA
04/2013
1Glutamic Acid (Glutamate)FDA Link
02/2013
1Memantine (Namenda)FDA Link
10/2012
1FibrinIBA
02/2012
1GluN2C-2D antagonist UBP145IBA
10/2011
1Peptide Hydrolases (Proteases)FDA Link
06/2011
1EndotoxinsIBA
08/2007
1LipopolysaccharidesIBA
08/2007
1CB2 Cannabinoid ReceptorIBA
04/2007
1Desmodus rotundus salivary plasminogen activator alpha 1IBA
03/2007
1NeuroserpinIBA
12/2005
1Evans Blue (Blue, Evans)FDA Link
05/2005
1PropionatesIBA
10/2004
1Kainic Acid (Kainate)IBA
10/2004
1tPA stopIBA
10/2004
1SerpinsIBA
08/2004
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
08/2004
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2003
1Transforming Growth Factor alpha (TGF-alpha)IBA
02/2003
1Epidermal Growth Factor (EGF)IBA
02/2003

Therapy/Procedure

7Therapeutics
02/2015 - 08/2004
3Intravenous Injections
04/2013 - 12/2002
1Thrombectomy
12/2018
1Lasers (Laser)
08/2017
1Immunotherapy
04/2013
1Thrombolytic Therapy
06/2008